RIGH SS - We’re moving beyond documents...........
Page 6
Beneficial Owners:
Name: Angel Stanz
Position: Chief Executive Officer
Securities Owned: 3,500,000 shares Series A Preferred
Name: Salvatore Tuzzolino
Position: Control Shareholder
Securities Owned: 26,655,792,728 shares common stock
Now, the difference between the two types of securities (Preferred vs. Common):
Page 2
Item III:
Security Information
Trading Symbol: RIGH
Exact Title and Class of Securities Outs.: Common Stock
CUSIP: 76657X 10 3
Total Shares Auth. As of 12/31/2013: 30,000,000,000
Total Shares Issued as of 12/31/2013: 29,999,999,468
Total Shares Outstanding as of 12/31/2013: 29,999,999,468
Additional Class of Securities:
Trading Symbol: None.
Exact Title and Class of Securities Outs.: Series A Preferred Stock.
CUSIP: None .
Total Shares Auth. As of 12/31/2013: 5,000,000
Total Shares Issued as of 12/31/2013: 3,565,000
Total Shares Outstanding as of 12/31/2013: 3,565,000
http://www.otcmarkets.com/financialReportView...;id=121609
RIGH Security Details
Share Structure
Market Value1 $15,000,000 a/o Aug 22, 2014
Shares Outstanding 29,999,999,468 a/o Mar 31, 2014
Float 3,294,206,740 a/o Apr 09, 2012
Authorized Shares 30,000,000,000 a/o Mar 27, 2014
Par Value 0.001
..........................................
Now add Mr. Tuzzolino's common to the float :
26,655,792,728 + 3,294,206,740 = 29,949,999,468
^^^^^ Mr. Tuzzonlino's shares added to the float = the O/S. ^^^^^^
Why? Because All Other Shares (i.e., Angel's shares) are Preferred Shares in an 'yet to be named' ticker.
And I believe those 26+ billion shares held by Sal are in the form of paper to maintain control of the company in case of any further bcap shenanigans.
http://investorshangout.com/post/view?id=1905934
Important Excerpts from the Q2/2014 Financials:
"In Q4 2012, the Company completed debt obligations that had been negotiated in the previous quarter. Upon completion, BG Medical reevaluated the relationship the company previously held with Baron Capital Enterprises (BCAP), a debt holder in the Company, and consultant to debt holders associated with the Company prior to the January 2012 reverse merger with BG Medical. Executive management concluded that financing commitments previously set forth by BCAP to BG Medical had not met expectations. As a result of an internal study examining historical transactions, management further alleged that ongoing actions by BCAP could cause irreparable harm to both Company and shareholders. To protect shareholder interests and future business interests, the Company sought to limit uncontrolled free trading shares from entering the marketplace from methodologies that that did not support business growth and/or shareholder earnings. Stopgap measures were put into place that limited corporate communications until a long-term strategy with sufficient resources had been established. The resultant lack of capital financing as previously planned, coupled with the presence of an unresolved capital financing relationship, created challenges for BG Medical in adhering to stated growth projections that were dependent upon capital support."
"Throughout 2013, the Company placed its focus on resolving market volatility allegedly resultant from a former financing relationship with Baron Capital Enterprises (BCAP) and its principals, an entity and individual(s) closely involved in providing past financing to the public entity prior to the 2012 reverse merger, and to a lesser degree, minor financing during the Q1 2012 and Q2 2012 post reverse merger period. BG Medical has no plans to enter into further debt arrangements with previous promissory note holders. The company wishes to distance itself from BCAP and remains committed to preserving shareholder value."
"As of Q4 2013, BG Medical successfully entered into capital agreements with a reputable finance firm to accelerate its proprietary technology development and to strengthen a market evaluation based on the Company’s future earning potential. BG Medical continues to seek accredited investors and respectable financial relationships to fulfill Company capital needs and growth development through its planned expansion."
"Upon facilitation of capital financing agreements erected in Q4 2013, new products and services for consumers and businesses are expected to resume development for enhancing the BudGenius software and data collection platform, including but not limited to, mobile app development, online transparency for laboratory workflow, marijuana genetics and strain mapping, marijuana heritage profiles to highlight sustained and exceptional farmer pedigree, business intelligence data gathering tools, consumer purchase pattern analysis, medical efficacy analysis, loyalty programs, portable diagnostic hardware for patients, and internal tools to optimize company workflow for the purpose of reducing cost of goods sold. A modified release schedule has not yet been determined."
"In 2009 through 2011 the Company entered into a series of promissory notes with Baron Capital Enterprise, Inc. The Company disputes the validity of the alleged obligations and claims damages against Baron Capital Enterprise, Inc. for, among other matters, material breach of contract."
As the Fins state, those 26+ billion shares held by Sal, are "Control Shares" (to maintain control of the company).
^^^^^And remember any legal action initiated by either company needs to be made public, and that hasn't happened . ^^^^^
What Angel had to say about Sal's shares, confirming my beliefs:
http://investorshangout.com/post/view?id=1544100
The above is all IMHO.
Page 6
Beneficial Owners:
Name: Angel Stanz
Position: Chief Executive Officer
Securities Owned: 3,500,000 shares Series A Preferred
Name: Salvatore Tuzzolino
Position: Control Shareholder
Securities Owned: 26,655,792,728 shares common stock
Now, the difference between the two types of securities (Preferred vs. Common):
Page 2
Item III:
Security Information
Trading Symbol: RIGH
Exact Title and Class of Securities Outs.: Common Stock
CUSIP: 76657X 10 3
Total Shares Auth. As of 12/31/2013: 30,000,000,000
Total Shares Issued as of 12/31/2013: 29,999,999,468
Total Shares Outstanding as of 12/31/2013: 29,999,999,468
Additional Class of Securities:
Trading Symbol: None.
Exact Title and Class of Securities Outs.: Series A Preferred Stock.
CUSIP: None .
Total Shares Auth. As of 12/31/2013: 5,000,000
Total Shares Issued as of 12/31/2013: 3,565,000
Total Shares Outstanding as of 12/31/2013: 3,565,000
http://www.otcmarkets.com/financialReportView...;id=121609
RIGH Security Details
Share Structure
Market Value1 $15,000,000 a/o Aug 22, 2014
Shares Outstanding 29,999,999,468 a/o Mar 31, 2014
Float 3,294,206,740 a/o Apr 09, 2012
Authorized Shares 30,000,000,000 a/o Mar 27, 2014
Par Value 0.001
..........................................
Now add Mr. Tuzzolino's common to the float :
26,655,792,728 + 3,294,206,740 = 29,949,999,468
^^^^^ Mr. Tuzzonlino's shares added to the float = the O/S. ^^^^^^
Why? Because All Other Shares (i.e., Angel's shares) are Preferred Shares in an 'yet to be named' ticker.
And I believe those 26+ billion shares held by Sal are in the form of paper to maintain control of the company in case of any further bcap shenanigans.
http://investorshangout.com/post/view?id=1905934
Important Excerpts from the Q2/2014 Financials:
"In Q4 2012, the Company completed debt obligations that had been negotiated in the previous quarter. Upon completion, BG Medical reevaluated the relationship the company previously held with Baron Capital Enterprises (BCAP), a debt holder in the Company, and consultant to debt holders associated with the Company prior to the January 2012 reverse merger with BG Medical. Executive management concluded that financing commitments previously set forth by BCAP to BG Medical had not met expectations. As a result of an internal study examining historical transactions, management further alleged that ongoing actions by BCAP could cause irreparable harm to both Company and shareholders. To protect shareholder interests and future business interests, the Company sought to limit uncontrolled free trading shares from entering the marketplace from methodologies that that did not support business growth and/or shareholder earnings. Stopgap measures were put into place that limited corporate communications until a long-term strategy with sufficient resources had been established. The resultant lack of capital financing as previously planned, coupled with the presence of an unresolved capital financing relationship, created challenges for BG Medical in adhering to stated growth projections that were dependent upon capital support."
"Throughout 2013, the Company placed its focus on resolving market volatility allegedly resultant from a former financing relationship with Baron Capital Enterprises (BCAP) and its principals, an entity and individual(s) closely involved in providing past financing to the public entity prior to the 2012 reverse merger, and to a lesser degree, minor financing during the Q1 2012 and Q2 2012 post reverse merger period. BG Medical has no plans to enter into further debt arrangements with previous promissory note holders. The company wishes to distance itself from BCAP and remains committed to preserving shareholder value."
"As of Q4 2013, BG Medical successfully entered into capital agreements with a reputable finance firm to accelerate its proprietary technology development and to strengthen a market evaluation based on the Company’s future earning potential. BG Medical continues to seek accredited investors and respectable financial relationships to fulfill Company capital needs and growth development through its planned expansion."
"Upon facilitation of capital financing agreements erected in Q4 2013, new products and services for consumers and businesses are expected to resume development for enhancing the BudGenius software and data collection platform, including but not limited to, mobile app development, online transparency for laboratory workflow, marijuana genetics and strain mapping, marijuana heritage profiles to highlight sustained and exceptional farmer pedigree, business intelligence data gathering tools, consumer purchase pattern analysis, medical efficacy analysis, loyalty programs, portable diagnostic hardware for patients, and internal tools to optimize company workflow for the purpose of reducing cost of goods sold. A modified release schedule has not yet been determined."
"In 2009 through 2011 the Company entered into a series of promissory notes with Baron Capital Enterprise, Inc. The Company disputes the validity of the alleged obligations and claims damages against Baron Capital Enterprise, Inc. for, among other matters, material breach of contract."
As the Fins state, those 26+ billion shares held by Sal, are "Control Shares" (to maintain control of the company).
^^^^^And remember any legal action initiated by either company needs to be made public, and that hasn't happened . ^^^^^
What Angel had to say about Sal's shares, confirming my beliefs:
http://investorshangout.com/post/view?id=1544100
The above is all IMHO.
